人力资本对医药制造业数字化转型的组态路径研究

    Research on the Configuration Path of Human Capital to the Digital Transformation of Pharmaceutical Manufacturing Industry

    • 摘要:
      目的  探究在数字化背景下,医药制造业如何发挥人力资本优势,促进企业数字化转型。
      方法 选取深沪A股上市的58家医药制造企业作为研究案例,运用模糊集定性比较分析(fuzzy sets qualitative comparative analysis,fsQCA)方法,从知识型人力资本、技术型人力资本、员工能力、人力资本配置规模、高管团队稳定性5方面探究高数字化转型成效的组态路径。
      结果 产生高数字化转型成效的路径有6条,企业应选择对应组态路径进行转型升级;员工能力是高数字化转型成效的必要条件;存在2组二阶等价组态,H3中非高人力资本配置规模与高高管团队稳定性可互相替代,H4中高知识型人力资本与高技术型人力资本可相互替代。
      结论  医药制造企业应重视人力资本5方面的协同作用,聚焦员工能力提升,以有效推动企业数字化转型。

       

      Abstract:
      OBJECTIVE  Exploring how the pharmaceutical manufacturing industry can exert the advantage of human capital to facilitate the digital transformation of enterprises in the digital context.
      METHODS  Selected 58 pharmaceutical manufacturing companies listed on the Shenzhen and Shanghai stock exchanges as the research case, and used the fuzzy set qualitative comparative analysis(fsQCA) method to explore the configuration path of high digital transformation effectiveness from five aspects: knowledge-based human capital, technical human capital, employee ability, human capital allocation scale, and executive team stability.
      RESULTS  There were 6 paths to produce high digital transformation effect, and enterprises should choose the corresponding configuration path for transformation and upgrading; Employee competence was a necessary condition for high digital transformation effectiveness; There were two second-order equivalent configurations, the non-high human capital allocation scale and high management team stability in H3 could replace each other, and the high knowledge human capital and high technology human capital in H4 could replace each other.
      CONCLUSION  Pharmaceutical manufacturing enterprises should attach importance to the synergy of the five aspects of human capital, focus on enhancing employees' capabilities, and effectively promote the digital transformation of the enterprise.

       

    /

    返回文章
    返回